Clinical Trial Update: Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PN2034 in insulin-dependent patients with Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PN2034

Snippet

Sponsor: Wellstat Therapeutics | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED